Regeneron Pharmaceuticals Inc

REGN

Sector
Healthcare

Industry
Biotechnology

Website
regeneron.com




Buy / Sell (dollars)

1 Month

14.1% 14.1% Complete (success)
85.9% 85.9% Complete (danger)
$1.301M
avg. $1.301M
$7.926M
avg. $7.926M

Buy/Sell Ratio

0.164

Transactions

5

Filers

2

3 Month

2.1% 2.1% Complete (success)
97.9% 97.9% Complete (danger)
$1.310M
avg. $436,770.83
$61.967M
avg. $20.656M

Buy/Sell Ratio

0.021

Transactions

10

Filers

5

12 Month

5.3% 5.3% Complete (success)
94.7% 94.7% Complete (danger)
$18.207M
avg. $1.517M
$326.564M
avg. $27.214M

Buy/Sell Ratio

0.056

Transactions

133

Filers

14

24 Month

26.4% 26.4% Complete (success)
73.6% 73.6% Complete (danger)
$218.587M
avg. $9.108M
$610.507M
avg. $25.438M

Buy/Sell Ratio

0.358

Transactions

323

Filers

17

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers